News

Filter

Astellas links with Harvard to discover new ophthalmic agents

14-10-2014

Japanese drug major Astellas Pharma has entered into a research collaboration with an investigator at…

Astellas PharmaLicensingOphthalmicsPharmaceuticalResearch

Regulator backs Inlyta, Lucentis and Xtandi for NHS Scotland, but not Bosulif

12-11-2013

The Scottish Medicines Consortium (SMC) revealed this morning (November 12) that it has accepted US drug…

Astellas PharmaBosulifEuropeInlytaLucentisNovartisOncologyOphthalmicsPfizerPharmaceuticalRegulationXtandi

COMPANY SPOTLIGHT

Menarini

Back to top